Trilogy Metals Inc. (NYSEAMERICAN:TMQ – Get Free Report) was the recipient of a significant decrease in short interest in the month of November. As of November 30th, there was short interest totalling 1,810,000 shares, a decrease of 25.2% from the November 15th total of 2,420,000 shares. Approximately 1.8% of the company’s shares are sold short. Based on an average daily volume of 1,680,000 shares, the days-to-cover ratio is currently 1.1 days.
Trilogy Metals Price Performance
Shares of Trilogy Metals stock remained flat at $1.13 on Friday. 141,426 shares of the stock were exchanged, compared to its average volume of 637,872. Trilogy Metals has a twelve month low of $0.25 and a twelve month high of $1.40. The stock has a market cap of $181.82 million, a P/E ratio of -18.83 and a beta of 1.59.
Trilogy Metals (NYSEAMERICAN:TMQ – Get Free Report) last issued its quarterly earnings results on Wednesday, October 9th. The mining company reported ($0.01) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.01). As a group, equities research analysts forecast that Trilogy Metals will post -0.04 earnings per share for the current year.
Institutional Inflows and Outflows
Trilogy Metals Company Profile
Trilogy Metals Inc, a base metals exploration company, engages in the exploration and development of mineral properties in the United States. The company explores for copper, cobalt, lead, zinc, gold, and silver properties. It principally holds interests in the Upper Kobuk mineral projects that include the Arctic, which contains polymetallic volcanogenic massive sulfide deposits; and Bornite that contains carbonate-hosted copper – cobalt deposits covering an area of approximately 448,217 acres located in the Ambler mining district in Northwest Alaska.
Read More
- Five stocks we like better than Trilogy Metals
- What is the FTSE 100 index?
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- What is a buyback in stocks? A comprehensive guide for investors
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Trilogy Metals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trilogy Metals and related companies with MarketBeat.com's FREE daily email newsletter.